clinical trial · NCT06026332
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Bladder CancerADSTILADRIN
brief summary
Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting
started
Sep 15, 2023
primary completion
Jan 15, 2026
completion
Jan 15, 2026
last updated
Feb 17, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol